Financhill
Sell
49

BCSF Quote, Financials, Valuation and Earnings

Last price:
$13.78
Seasonality move :
-2.58%
Day range:
$13.82 - $13.99
52-week range:
$13.20 - $19.21
Dividend yield:
12.08%
P/E ratio:
9.67x
P/S ratio:
3.85x
P/B ratio:
0.80x
Volume:
480.9K
Avg. volume:
446.1K
1-year change:
-20.61%
Market cap:
$902.3M
Revenue:
$284.5M
EPS (TTM):
$1.44

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BCSF
Bain Capital Specialty Finance, Inc.
$68.5M $0.47 8.38% 37.07% $15.17
ARCC
Ares Capital Corp.
$795.2M $0.50 8.49% -8.61% $22.64
COHN
Cohen & Co., Inc.
-- -- -- -- --
CSWC
Capital Southwest
$57.4M $0.57 46.48% 89.62% $23.58
RAND
Rand Capital Corp.
-- -- -- -- --
SCM
Stellus Capital Investment Corp.
$26.4M $0.30 -16.52% -6.73% $13.10
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BCSF
Bain Capital Specialty Finance, Inc.
$13.91 $15.17 $902.3M 9.67x $0.15 12.08% 3.85x
ARCC
Ares Capital Corp.
$20.23 $22.64 $14.5B 10.16x $0.48 9.49% 4.27x
COHN
Cohen & Co., Inc.
$23.57 -- $48M 9.91x $0.25 4.24% 0.27x
CSWC
Capital Southwest
$22.15 $23.58 $1.3B 14.26x $0.25 10.48% 6.50x
RAND
Rand Capital Corp.
$11.36 -- $33.7M 6.67x $0.85 10.22% 6.05x
SCM
Stellus Capital Investment Corp.
$12.68 $13.10 $367.1M 11.64x $0.13 12.62% 3.40x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BCSF
Bain Capital Specialty Finance, Inc.
57.01% 0.659 161.88% 2.57x
ARCC
Ares Capital Corp.
52.14% 0.669 106.78% 1.47x
COHN
Cohen & Co., Inc.
91.38% -0.172 666.78% 0.09x
CSWC
Capital Southwest
52.33% 0.392 83.49% 0.32x
RAND
Rand Capital Corp.
-- 0.409 -- 16.03x
SCM
Stellus Capital Investment Corp.
62.6% 0.710 168.28% 11.09x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BCSF
Bain Capital Specialty Finance, Inc.
$42.4M $39.7M 3.61% 8.17% 70.26% $49.9M
ARCC
Ares Capital Corp.
$804M $641M 4.9% 10% 63.03% $365M
COHN
Cohen & Co., Inc.
$251.5M $32.9M 0.95% 7.96% 12.92% $364.6M
CSWC
Capital Southwest
$51M $45.5M 4.72% 9.75% 86.19% $26M
RAND
Rand Capital Corp.
-$1.7M -$2.2M -19.11% -19.38% 164.35% $491.8K
SCM
Stellus Capital Investment Corp.
$22.3M $16.3M 3.1% 8.2% 56.04% $4.5M

Bain Capital Specialty Finance, Inc. vs. Competitors

  • Which has Higher Returns BCSF or ARCC?

    Ares Capital Corp. has a net margin of 33.13% compared to Bain Capital Specialty Finance, Inc.'s net margin of 39.73%. Bain Capital Specialty Finance, Inc.'s return on equity of 8.17% beat Ares Capital Corp.'s return on equity of 10%.

    Company Gross Margin Earnings Per Share Invested Capital
    BCSF
    Bain Capital Specialty Finance, Inc.
    75.15% $0.29 $2.6B
    ARCC
    Ares Capital Corp.
    79.06% $0.57 $29.9B
  • What do Analysts Say About BCSF or ARCC?

    Bain Capital Specialty Finance, Inc. has a consensus price target of $15.17, signalling upside risk potential of 9.03%. On the other hand Ares Capital Corp. has an analysts' consensus of $22.64 which suggests that it could grow by 11.93%. Given that Ares Capital Corp. has higher upside potential than Bain Capital Specialty Finance, Inc., analysts believe Ares Capital Corp. is more attractive than Bain Capital Specialty Finance, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BCSF
    Bain Capital Specialty Finance, Inc.
    1 1 0
    ARCC
    Ares Capital Corp.
    9 2 0
  • Is BCSF or ARCC More Risky?

    Bain Capital Specialty Finance, Inc. has a beta of 0.602, which suggesting that the stock is 39.788% less volatile than S&P 500. In comparison Ares Capital Corp. has a beta of 0.584, suggesting its less volatile than the S&P 500 by 41.593%.

  • Which is a Better Dividend Stock BCSF or ARCC?

    Bain Capital Specialty Finance, Inc. has a quarterly dividend of $0.15 per share corresponding to a yield of 12.08%. Ares Capital Corp. offers a yield of 9.49% to investors and pays a quarterly dividend of $0.48 per share. Bain Capital Specialty Finance, Inc. pays 90.83% of its earnings as a dividend. Ares Capital Corp. pays out 78.72% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BCSF or ARCC?

    Bain Capital Specialty Finance, Inc. quarterly revenues are $56.4M, which are smaller than Ares Capital Corp. quarterly revenues of $1B. Bain Capital Specialty Finance, Inc.'s net income of $18.7M is lower than Ares Capital Corp.'s net income of $404M. Notably, Bain Capital Specialty Finance, Inc.'s price-to-earnings ratio is 9.67x while Ares Capital Corp.'s PE ratio is 10.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bain Capital Specialty Finance, Inc. is 3.85x versus 4.27x for Ares Capital Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BCSF
    Bain Capital Specialty Finance, Inc.
    3.85x 9.67x $56.4M $18.7M
    ARCC
    Ares Capital Corp.
    4.27x 10.16x $1B $404M
  • Which has Higher Returns BCSF or COHN?

    Cohen & Co., Inc. has a net margin of 33.13% compared to Bain Capital Specialty Finance, Inc.'s net margin of 3.45%. Bain Capital Specialty Finance, Inc.'s return on equity of 8.17% beat Cohen & Co., Inc.'s return on equity of 7.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    BCSF
    Bain Capital Specialty Finance, Inc.
    75.15% $0.29 $2.6B
    COHN
    Cohen & Co., Inc.
    98.84% $2.58 $608.2M
  • What do Analysts Say About BCSF or COHN?

    Bain Capital Specialty Finance, Inc. has a consensus price target of $15.17, signalling upside risk potential of 9.03%. On the other hand Cohen & Co., Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Bain Capital Specialty Finance, Inc. has higher upside potential than Cohen & Co., Inc., analysts believe Bain Capital Specialty Finance, Inc. is more attractive than Cohen & Co., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BCSF
    Bain Capital Specialty Finance, Inc.
    1 1 0
    COHN
    Cohen & Co., Inc.
    0 0 0
  • Is BCSF or COHN More Risky?

    Bain Capital Specialty Finance, Inc. has a beta of 0.602, which suggesting that the stock is 39.788% less volatile than S&P 500. In comparison Cohen & Co., Inc. has a beta of 1.240, suggesting its more volatile than the S&P 500 by 24.029%.

  • Which is a Better Dividend Stock BCSF or COHN?

    Bain Capital Specialty Finance, Inc. has a quarterly dividend of $0.15 per share corresponding to a yield of 12.08%. Cohen & Co., Inc. offers a yield of 4.24% to investors and pays a quarterly dividend of $0.25 per share. Bain Capital Specialty Finance, Inc. pays 90.83% of its earnings as a dividend. Cohen & Co., Inc. pays out -22.87% of its earnings as a dividend. Bain Capital Specialty Finance, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BCSF or COHN?

    Bain Capital Specialty Finance, Inc. quarterly revenues are $56.4M, which are smaller than Cohen & Co., Inc. quarterly revenues of $254.4M. Bain Capital Specialty Finance, Inc.'s net income of $18.7M is higher than Cohen & Co., Inc.'s net income of $8.8M. Notably, Bain Capital Specialty Finance, Inc.'s price-to-earnings ratio is 9.67x while Cohen & Co., Inc.'s PE ratio is 9.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bain Capital Specialty Finance, Inc. is 3.85x versus 0.27x for Cohen & Co., Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BCSF
    Bain Capital Specialty Finance, Inc.
    3.85x 9.67x $56.4M $18.7M
    COHN
    Cohen & Co., Inc.
    0.27x 9.91x $254.4M $8.8M
  • Which has Higher Returns BCSF or CSWC?

    Capital Southwest has a net margin of 33.13% compared to Bain Capital Specialty Finance, Inc.'s net margin of 48%. Bain Capital Specialty Finance, Inc.'s return on equity of 8.17% beat Capital Southwest's return on equity of 9.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    BCSF
    Bain Capital Specialty Finance, Inc.
    75.15% $0.29 $2.6B
    CSWC
    Capital Southwest
    96.68% $0.44 $2B
  • What do Analysts Say About BCSF or CSWC?

    Bain Capital Specialty Finance, Inc. has a consensus price target of $15.17, signalling upside risk potential of 9.03%. On the other hand Capital Southwest has an analysts' consensus of $23.58 which suggests that it could grow by 6.47%. Given that Bain Capital Specialty Finance, Inc. has higher upside potential than Capital Southwest, analysts believe Bain Capital Specialty Finance, Inc. is more attractive than Capital Southwest.

    Company Buy Ratings Hold Ratings Sell Ratings
    BCSF
    Bain Capital Specialty Finance, Inc.
    1 1 0
    CSWC
    Capital Southwest
    3 3 0
  • Is BCSF or CSWC More Risky?

    Bain Capital Specialty Finance, Inc. has a beta of 0.602, which suggesting that the stock is 39.788% less volatile than S&P 500. In comparison Capital Southwest has a beta of 0.766, suggesting its less volatile than the S&P 500 by 23.352%.

  • Which is a Better Dividend Stock BCSF or CSWC?

    Bain Capital Specialty Finance, Inc. has a quarterly dividend of $0.15 per share corresponding to a yield of 12.08%. Capital Southwest offers a yield of 10.48% to investors and pays a quarterly dividend of $0.25 per share. Bain Capital Specialty Finance, Inc. pays 90.83% of its earnings as a dividend. Capital Southwest pays out 157.4% of its earnings as a dividend. Bain Capital Specialty Finance, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Capital Southwest's is not.

  • Which has Better Financial Ratios BCSF or CSWC?

    Bain Capital Specialty Finance, Inc. quarterly revenues are $56.4M, which are larger than Capital Southwest quarterly revenues of $52.8M. Bain Capital Specialty Finance, Inc.'s net income of $18.7M is lower than Capital Southwest's net income of $25.3M. Notably, Bain Capital Specialty Finance, Inc.'s price-to-earnings ratio is 9.67x while Capital Southwest's PE ratio is 14.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bain Capital Specialty Finance, Inc. is 3.85x versus 6.50x for Capital Southwest. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BCSF
    Bain Capital Specialty Finance, Inc.
    3.85x 9.67x $56.4M $18.7M
    CSWC
    Capital Southwest
    6.50x 14.26x $52.8M $25.3M
  • Which has Higher Returns BCSF or RAND?

    Rand Capital Corp. has a net margin of 33.13% compared to Bain Capital Specialty Finance, Inc.'s net margin of -482.82%. Bain Capital Specialty Finance, Inc.'s return on equity of 8.17% beat Rand Capital Corp.'s return on equity of -19.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    BCSF
    Bain Capital Specialty Finance, Inc.
    75.15% $0.29 $2.6B
    RAND
    Rand Capital Corp.
    -- -$0.75 $53.6M
  • What do Analysts Say About BCSF or RAND?

    Bain Capital Specialty Finance, Inc. has a consensus price target of $15.17, signalling upside risk potential of 9.03%. On the other hand Rand Capital Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Bain Capital Specialty Finance, Inc. has higher upside potential than Rand Capital Corp., analysts believe Bain Capital Specialty Finance, Inc. is more attractive than Rand Capital Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    BCSF
    Bain Capital Specialty Finance, Inc.
    1 1 0
    RAND
    Rand Capital Corp.
    0 0 0
  • Is BCSF or RAND More Risky?

    Bain Capital Specialty Finance, Inc. has a beta of 0.602, which suggesting that the stock is 39.788% less volatile than S&P 500. In comparison Rand Capital Corp. has a beta of 0.289, suggesting its less volatile than the S&P 500 by 71.129%.

  • Which is a Better Dividend Stock BCSF or RAND?

    Bain Capital Specialty Finance, Inc. has a quarterly dividend of $0.15 per share corresponding to a yield of 12.08%. Rand Capital Corp. offers a yield of 10.22% to investors and pays a quarterly dividend of $0.85 per share. Bain Capital Specialty Finance, Inc. pays 90.83% of its earnings as a dividend. Rand Capital Corp. pays out 147.07% of its earnings as a dividend. Bain Capital Specialty Finance, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Rand Capital Corp.'s is not.

  • Which has Better Financial Ratios BCSF or RAND?

    Bain Capital Specialty Finance, Inc. quarterly revenues are $56.4M, which are larger than Rand Capital Corp. quarterly revenues of -$1.3M. Bain Capital Specialty Finance, Inc.'s net income of $18.7M is higher than Rand Capital Corp.'s net income of -$2.2M. Notably, Bain Capital Specialty Finance, Inc.'s price-to-earnings ratio is 9.67x while Rand Capital Corp.'s PE ratio is 6.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bain Capital Specialty Finance, Inc. is 3.85x versus 6.05x for Rand Capital Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BCSF
    Bain Capital Specialty Finance, Inc.
    3.85x 9.67x $56.4M $18.7M
    RAND
    Rand Capital Corp.
    6.05x 6.67x -$1.3M -$2.2M
  • Which has Higher Returns BCSF or SCM?

    Stellus Capital Investment Corp. has a net margin of 33.13% compared to Bain Capital Specialty Finance, Inc.'s net margin of 22.96%. Bain Capital Specialty Finance, Inc.'s return on equity of 8.17% beat Stellus Capital Investment Corp.'s return on equity of 8.2%.

    Company Gross Margin Earnings Per Share Invested Capital
    BCSF
    Bain Capital Specialty Finance, Inc.
    75.15% $0.29 $2.6B
    SCM
    Stellus Capital Investment Corp.
    76.46% $0.24 $1B
  • What do Analysts Say About BCSF or SCM?

    Bain Capital Specialty Finance, Inc. has a consensus price target of $15.17, signalling upside risk potential of 9.03%. On the other hand Stellus Capital Investment Corp. has an analysts' consensus of $13.10 which suggests that it could grow by 3.31%. Given that Bain Capital Specialty Finance, Inc. has higher upside potential than Stellus Capital Investment Corp., analysts believe Bain Capital Specialty Finance, Inc. is more attractive than Stellus Capital Investment Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    BCSF
    Bain Capital Specialty Finance, Inc.
    1 1 0
    SCM
    Stellus Capital Investment Corp.
    1 5 0
  • Is BCSF or SCM More Risky?

    Bain Capital Specialty Finance, Inc. has a beta of 0.602, which suggesting that the stock is 39.788% less volatile than S&P 500. In comparison Stellus Capital Investment Corp. has a beta of 0.663, suggesting its less volatile than the S&P 500 by 33.71%.

  • Which is a Better Dividend Stock BCSF or SCM?

    Bain Capital Specialty Finance, Inc. has a quarterly dividend of $0.15 per share corresponding to a yield of 12.08%. Stellus Capital Investment Corp. offers a yield of 12.62% to investors and pays a quarterly dividend of $0.13 per share. Bain Capital Specialty Finance, Inc. pays 90.83% of its earnings as a dividend. Stellus Capital Investment Corp. pays out 89.31% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BCSF or SCM?

    Bain Capital Specialty Finance, Inc. quarterly revenues are $56.4M, which are larger than Stellus Capital Investment Corp. quarterly revenues of $29.1M. Bain Capital Specialty Finance, Inc.'s net income of $18.7M is higher than Stellus Capital Investment Corp.'s net income of $6.7M. Notably, Bain Capital Specialty Finance, Inc.'s price-to-earnings ratio is 9.67x while Stellus Capital Investment Corp.'s PE ratio is 11.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bain Capital Specialty Finance, Inc. is 3.85x versus 3.40x for Stellus Capital Investment Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BCSF
    Bain Capital Specialty Finance, Inc.
    3.85x 9.67x $56.4M $18.7M
    SCM
    Stellus Capital Investment Corp.
    3.40x 11.64x $29.1M $6.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 6.12% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.13% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 7.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock